Kite Pharma (KITE) Tops Q2 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/11/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts KITE Hot Sheet
Join SI Premium – FREE
Kite Pharma (NASDAQ: KITE) reported Q2 EPS of ($0.26), $0.14 better than the analyst estimate of ($0.40). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $2.51 million.
For earnings history and earnings-related data on Kite Pharma (KITE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Top AI Semiconductor Stocks According to Stifel Analysis
- UBS Reiterates Buy Rating on Pepsico (PEP) on Q3 Beat
- vVardis files for US IPO showing net loss, revenue growth
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
